Back |
home / stock / kdmn / kdmn message board
Subject | By | Source | When |
---|---|---|---|
* * $KDMN Video Chart 10-26-18 * * | ClayTrader | investorshub | 10/26/2018 8:08:41 PM |
KD025 just got Breakthrough Therapy Designation from the | mcp4 | investorshub | 10/17/2018 6:22:12 PM |
MetLife Investment Advisors has acquired 37K more shares | mcp4 | investorshub | 10/15/2018 7:43:48 PM |
Ouch. 52 week low. Not much | mcp4 | investorshub | 10/10/2018 7:57:05 PM |
1.4M $KDMN shares were just purchased by VHCP | mcp4 | investorshub | 09/05/2018 11:09:00 AM |
HC Wainwright has given $KDMN a Buy rating | mcp4 | investorshub | 08/24/2018 5:50:17 PM |
duplicate | mcp4 | investorshub | 08/21/2018 1:49:27 PM |
Zacks has rated Kadmon buy but contradicts their | mcp4 | investorshub | 08/21/2018 1:49:26 PM |
New research paper is out regarding KD025, the | mcp4 | investorshub | 08/15/2018 6:26:34 PM |
2Q 2018 10-K is out. | mcp4 | investorshub | 08/09/2018 10:36:35 PM |
Annual meeting announced for July 27th at the | mcp4 | investorshub | 07/03/2018 4:02:22 PM |
* * $KDMN Video Chart 06-12-18 * * | ClayTrader | investorshub | 06/12/2018 8:50:16 PM |
News, Short Squeeze, Breakout and More Instantly...
Kadmon Holdings Inc. Company Name:
KDMN Stock Symbol:
NYSE Market:
- REZUROCK™ (belumosudil) 200 mg once daily (QD) tablets are now commercially available for shipment to prescribed patients in the United States - - Execution of strategic launch strategy underway; Third quarter REZUROCK net sales $12.2 million - - Sanofi acquisition of Kadm...
NEW YORK, NY / ACCESSWIRE / October 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced it will present data from the ongoing Phase 1 clinical trial of KD033, its anti-PD-L1/IL-15 fusion protein, in patients with metastatic or locally advanced solid tumors, in addition to other IL-...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Kadmon Holdings, Inc. Skyrockets Amid Entering Definitive Merger Agreement with Sanofi Kadmon Holdings, Inc. (NASDAQ: KDMN) surged 73% in premarket trading after entering...